Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections

NCT00621192 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Necrotizing Enterocolitis
Intra-abdominal Infection

Interventions

DRUG: meropenem

Sponsor

The Emmes Company, LLC